Literature DB >> 7979281

Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus.

D P Nicolau1, C D Freeman, C H Nightingale, C J Coe, R Quintiliani.   

Abstract

The purpose of this study was to determine the penetration of minocycline and vancomycin into cardiac vegetations and to determine their efficacy in a rabbit model of endocarditis caused by oxacillin-resistant Staphylococcus aureus. Animals were randomized into three groups: control (no antibiotic), minocycline (6 mg/kg given intravenously every 8 h), and vancomycin (50 mg/kg given intravenously every 8 h). Penetration of the antibiotics into aortic valve vegetations was determined by using the tissue/serum area under the concentration-time curve ratio. The reductions in the bacterial density of the vegetations caused by both vancomycin (4.8 +/- 1.2 CFU/g) and minocycline (5.3 +/- 1.6 CFU/g) were significantly different from that of controls (8.7 +/- 1.8 CFU/g). Although the penetration of minocycline was twice that of vancomycin, they were equally effective in reducing the bacterial density of the vegetations, since the concentrations of both agents in tissue remained above their MICs for oxacillin-resistant S. aureus. For organisms for which the MICs are higher, however, these penetration differences may result in treatment differences.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979281      PMCID: PMC284585          DOI: 10.1128/AAC.38.7.1515

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Methicillin-resistant Staphylococcus aureus.

Authors:  W Brumfitt; J Hamilton-Miller
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

2.  [A child case of infective endocarditis due to methicillin-resistant Staphylococcus aureus--analysis of the therapeutic course and drug sensitivity of detected organisms].

Authors:  S Iwata; Y Yamashita; H Iwai; N Kumagai; S Kusano; T Asaishi; M Okura; K Nishikawa; C Kawashima; T Aoki
Journal:  Kansenshogaku Zasshi       Date:  1987-02

3.  Treatment of prosthetic valve endocarditis due to methicillin-resistant Staphylococcus aureus with minocycline.

Authors:  M T Lawlor; M C Sullivan; R E Levitz; R Quintiliani; C Nightingale
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

4.  [A case of Staphylococcus aureus septicemia after acupuncture therapy].

Authors:  Y Doutsu; Y Tao; K Sasayama; Y Inoue; K Yamashita; H Shigeno; Y Miyazaki; H Koga; M Nagasawa; Y Fukuda
Journal:  Kansenshogaku Zasshi       Date:  1986-08

5.  Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-03       Impact factor: 2.378

6.  [A case report of sepsis and multiple lung abscess associated with purulent arthritis of knee joint due to methicillin resistant Staphylococcus aureus].

Authors:  K Watanabe; T Takase; A Kinoshita; T Ishino; H Kawabe; T Yamazumi; S Kono; T Hayashi; K Yamaguchi; K Hara
Journal:  Kansenshogaku Zasshi       Date:  1988-03

7.  Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci.

Authors:  A Bouvet; A C Cremieux; A Contrepois; J M Vallois; C Lamesch; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

8.  A microtechnique for the determination of antibiotics in muscle.

Authors:  O Cars; S Ogren
Journal:  J Antimicrob Chemother       Date:  1981-07       Impact factor: 5.790

9.  Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci.

Authors:  J N Minuth; T M Holmes; D M Musher
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

10.  In vitro activity of minocycline and rifampin against staphylococci.

Authors:  J Segreti; L C Gvazdinskas; G M Trenholme
Journal:  Diagn Microbiol Infect Dis       Date:  1989 May-Jun       Impact factor: 2.803

View more
  12 in total

Review 1.  Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.

Authors:  G M Eliopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

2.  Rapid decrease of free vancomycin in dense staphylococcal cultures.

Authors:  C Ekdahl; H Hanberger; A Hällgren; M Nilsson; E Svensson; L E Nilsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

Review 3.  Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.

Authors:  B A Cunha; J Baron; C B Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-17       Impact factor: 3.267

4.  Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditis.

Authors:  D P Nicolau; M N Marangos; C H Nightingale; K B Patel; B W Cooper; R Quintiliani; P Courvalin; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

5.  Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis.

Authors:  R C Mercier; M J Rybak; A S Bayer; M R Yeaman
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.

Authors:  Mustafa Sacar; Suzan Sacar; Nural Cevahir; Gokhan Onem; Zafer Teke; Ali Asan; Huseyin Turgut; Fahri Adali; Ilknur Kaleli; Ibrahim Susam; Yalin Tolga Yaylali; Ahmet Baltalarli
Journal:  Tex Heart Inst J       Date:  2010

7.  Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  Jörg J Ruhe; Anupama Menon
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

8.  Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.

Authors:  M W Climo; R L Patron; B P Goldstein; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

9.  Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model.

Authors:  Karen E Bowker; Alan R Noel; Alasdair P Macgowan
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

10.  Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations.

Authors:  J R Aeschlimann; M J Zervos; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.